Cartesian Therapeutics Inc (RNAC) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access RNAC Annual Balance Sheets →
Reviewing balance sheet data across recent quarters allows users to assess how Cartesian Therapeutics Inc manages assets, liabilities, and equity through different cycles.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2026)
(Dec 31 2025) (Sep 30 2025) (Jun 30 2025) (Mar 31 2025)
Assets
Cash & cash equivalent118.64
Cash & Short-term Investments118.00
Accounts receivable0.26
Other Current Assets0.00
Prepaid Expense And Other Assets Current3.14
Total Current Assets122.04
Equipment/Property/Plant Net11.64
Goodwill net48.16
Intangible Assets93.90
Long-term investments1.74
Other Assets, Noncurrent12.65
Operating Lease Right Of Use Asset5.37
Total Assets288.39
Liabilities
Accounts Payable, Current AC1.60
Accrued Liabilities And Other Liabilities10.16
Other Liabilities, Current4.19
Total Current Liabilities15.95
Total Long-term Debt0.00
Other liabilities, Noncurrent420.56
DeferredIncomeTaxLiabilitiesNet6.95
Operating Lease Liability Current4.19
Total Liabilities436.51
Stockholders' Equity
Common Stock Value0.00
Additional Paid In Capital Common Stock718.02
Retained Earnings / Accumulated Deficit-861.56
Defined Benefit Plan and Other0.00
Other Equity-4.58
Common Stockholder's Equity-148.12
Total Stockholder's Equity-148.12
Liabilities & Stockholder's Equity288.39
4 historic quarters locked

Sign in to unlock the full Cartesian Therapeutics Inc balance sheet history.

About Cartesian Therapeutics Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001453687-26-000101

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.